Deborah Heart and Lung Center

05/29/2026 | News release | Archived content

New Frontiers in Heart Valve Disease Treatment

Heart valve disease affects millions in the US. The four heart valves: aortic, mitral, pulmonary and tricuspid, ensure that blood flows properly through the heart. Valve disease includes the following conditions:

  • Stenosis, a valve that does not open properly
  • Regurgitation, a leaky valve
  • Prolapse, floppy valve leaflets that don't close properly
  • Atresia, a congenital heart defect.

Valve disease can stress the heart, and if not treated, can cause serious life-threatening complications.

Fortunately, options exist for valve repair and replacement. Traditionally the heart's valves were repaired and replaced through open surgery. Now, minimally invasive, catheter-based options are available. In this episode, KYW's Rasa Kaye speaks with Muhammad Raza, MD, Deborah's Medical Director, Structural Heart Program and Division Director, Interventional Cardiology, who discusses new advancements and procedures for addressing valve disease.

Transcatheter mitral valve replacement (TMVR) is the newest option available to address mitral valve disease. Dr. Raza explains this exciting advancement and its implications for people with mitral valve disease.

Deborah Heart and Lung Center published this content on May 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 23, 2026 at 23:35 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]